(Q40257863)

18 September 2017

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer (English)

1 reference

18 September 2017

Zhihong Ai

1

1 reference

18 September 2017

Lianhua Yin

2

1 reference

18 September 2017

Xianrong Zhou

3

1 reference

18 September 2017

Ying Zhu

4

1 reference

18 September 2017

Dongmei Zhu

5

1 reference

18 September 2017

Yinhua Yu

6

1 reference

18 September 2017

Youji Feng

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

18 September 2017

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

18 September 2017

107

1 reference

18 September 2017

746-756

1 reference

18 September 2017

4

1 reference

18 September 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Validating survivin as a cancer therapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Epidermal growth factor receptor expression in three different human endometrial cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22044

7 January 2021

Identifiers

DOI

10.1002/CNCR.22044

1 reference

18 September 2017

1 reference